首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Journal of Breast Cancer
ISSN：1738-6756

Journal of Breast Cancer

J BREAST CANCER
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学4区
年发文量：35
影响因子：2.4
JCR分区：Q3
期刊官网： http://ejbc.kr/

基本信息

《乳腺癌杂志》（英语：Journal of Breast Cancer）是韩国乳腺癌协会的官方杂志，自1998年起每季度在每年的3月、6月、9月和12月的最后一天发行。《日刊》的所有内容可在《日刊》官方网站（http：//www.example.com）上查阅ejbc.kr，并实行开放获取政策。该杂志旨在为对乳腺癌感兴趣的医生、基础科学研究人员和卫生保健专业人员之间提供一个学术交流的论坛。为了达到这一目标，我们发表原创调查、综述文章、简短通讯，包括病例报告、对乳腺癌重要主题的编辑意见，并欢迎新的研究发现和流行病学研究，特别是当它们包含区域数据时，以抓住国际读者的兴趣。虽然该杂志主要讨论乳腺癌问题，但也可以发表良性乳腺疾病中的罕见病例或为临床实践提供有用信息的循证科学文章。
1738-6756SCIE/Scopus收录/DOAJ开放期刊
2.4
点击查看最新影响趋势>
3.5
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ONCOLOGY
SCIE
Q3
200/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ONCOLOGY
SCIE
Q3
209/328
29
35
点击查看年发文量趋势图>
28%容易较慢,6-12周-医学-肿瘤学
4.2%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
91.43%100%10%
CiteScore：4.00
SJR：0.760
SNIP：0.807
学科类别分区排名百分位
大类：Medicine
小类：Oncology
Q2
208 / 415
大类：Medicine
小类：Cancer Research
Q3
153 / 233

期刊高被引文献

Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e5
miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e19
Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e38
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e39
The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e41
BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e6
Inhibition of Indoleamine 2,3-Dioxygenase Enhances the Therapeutic Efficacy of Immunogenic Chemotherapeutics in Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e23
c-Myc-Induced Long Non-Coding RNA Small Nucleolar RNA Host Gene 7 Regulates Glycolysis in Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e54
Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e8
Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e29
Kinesin Family Member 11 Enhances the Self-Renewal Ability of Breast Cancer Cells by Participating in the Wnt/β-Catenin Pathway
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e51
Prognostic Role of KRAS mRNA Expression in Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e55
Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e56
Pokemon Inhibits Transforming Growth Factor β-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e11
Immediate Breast Reconstruction Does Not Have a Clinically Significant Impact on Adjuvant Treatment Delay and Subsequent Survival Outcomes
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e7
High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e20
In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e43
Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e17
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e49
Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e18
Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e48
Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e53
Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype− Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e35
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e21
Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e46
Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e16
Comparison of Digital and Screen-Film Mammography for Breast-Cancer Screening: A Systematic Review and Meta-Analysis
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e24
Intraoperative Specimen Mammography for Margin Assessment in Breast-Conserving Surgery
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e58
Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e10
Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e4
Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e3
Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e47
Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e13
A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e57
Murine Model Study of a New Receptor-Targeted Tracer for Sentinel Lymph Node in Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e28
Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e33
Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e2
CD9 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Lobular Carcinoma
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e9
Skin-sparing Mastectomy and Immediate Nipple Graft for Large, Ptotic Breast
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e52
Ribociclib-Related Stevens–Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e44
Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insertion in Breast Cancer Patients: A Retrospective Case-control Study
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e40
Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e14
Salivary Duct Cancer Metastasis Mimicking Primary Breast Cancer: A Case Report and Review
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e45
Clinical Effects of Hypomethylating Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received DNA-Damaging Chemotherapy for Metastatic Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e50
Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e37
The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e25
Gastric Complications after Adjuvant Radiotherapy for Breast Cancer
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e42
Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e31
Erratum: Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e12
Primary Histiocytic Sarcoma Presenting as a Breast Mass: A Case Report
来源期刊：Journal of Breast CancerDOI：10.4048/jbc.2019.22.e32

相关文章

Journal of Breast Cancer：乳腺癌领域好刊，低费用OA出版，审稿速度良好
2025-06-16
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
否
否